NuPathe gets more funding to launch Zelrix migraine patch
Page 1 of 1
NuPathe gets more funding to launch Zelrix migraine patch
NuPathe gets more funding to launch Zelrix migraine patch
Philadelphia Business Journal - by John George , Staff Writer
Date: Tuesday, June 14, 2011, 10:16am EDT - Last Modified: Tuesday, June 14, 2011, 2:49pm EDT
Related: Health Care
NuPathe prepares for Zelrix migraine patch launch ICG picked tech company of year
NuPathe Inc. said Tuesday it has received an additional $10 million term loan under its secured credit facility.
Jane H. Hollingsworth, CEO of NuPathe (NASDAQ:PATH), said the move will provide the Conshohocken, Pa., specialty pharmaceutical company with “additional financial flexibility” as it continues to prepare for the potential launch of Zelrix, a transdermal patch it has developed to treat migraine headaches.
The Food and Drug Administration is scheduled to rule on NuPathe’s new drug application for Zelrix in August. Hollingsworth said the company expects to launch the drug during the first half of next year.
Philadelphia Business Journal - by John George , Staff Writer
Date: Tuesday, June 14, 2011, 10:16am EDT - Last Modified: Tuesday, June 14, 2011, 2:49pm EDT
Related: Health Care
NuPathe prepares for Zelrix migraine patch launch ICG picked tech company of year
NuPathe Inc. said Tuesday it has received an additional $10 million term loan under its secured credit facility.
Jane H. Hollingsworth, CEO of NuPathe (NASDAQ:PATH), said the move will provide the Conshohocken, Pa., specialty pharmaceutical company with “additional financial flexibility” as it continues to prepare for the potential launch of Zelrix, a transdermal patch it has developed to treat migraine headaches.
The Food and Drug Administration is scheduled to rule on NuPathe’s new drug application for Zelrix in August. Hollingsworth said the company expects to launch the drug during the first half of next year.
Similar topics
» Zelrix Migraine Patch – FDA Approval Delayed
» My 30-year headache - but refused NHS funding
» New drug - known as Zelrix and NP101 - safety trails results
» New Paper - Written by the City of London Migraine Clinic - Progress in the Pharmacotherapy of Menstrual Migraine
» Migraine Actions -Challenging Migraine October 2011 newsletter is now available online
» My 30-year headache - but refused NHS funding
» New drug - known as Zelrix and NP101 - safety trails results
» New Paper - Written by the City of London Migraine Clinic - Progress in the Pharmacotherapy of Menstrual Migraine
» Migraine Actions -Challenging Migraine October 2011 newsletter is now available online
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Thu Mar 30, 2017 9:04 am by Sarah
» Facebook group - now set up
Fri Feb 24, 2017 7:43 am by Tee
» cluster headache
Wed Feb 15, 2017 3:51 pm by Heregailing
» Your view on migraines and social media
Fri Feb 10, 2017 4:17 am by Tee
» Fats and Chronic Pain/Headaches
Thu May 19, 2016 10:52 pm by Sarah
» National hospital - London
Sun Jan 10, 2016 3:18 pm by pīwakawaka
» Just saying Hello
Sun Jan 10, 2016 3:12 pm by pīwakawaka
» Botox for harmeplegic migraines
Thu Sep 24, 2015 10:59 pm by Robyn17
» Hello and thank you
Mon May 25, 2015 12:55 am by ajdesq